Evotec SE (EVO) Cash & Equivalents (2009 - 2026)
Evotec SE (EVO) reported Cash & Equivalents of $404.92 million for the quarter ended Jun 30, 2026, up 33.6% from $303.17 million a year earlier but down 10.8% from the prior quarter.
Powered by 
Analysis
Evotec SE (EVO) Cash & Equivalents (2009 - 2026) Analysis & Trends
As of Dec 31, 2025, Evotec SE posted Cash & Equivalents of $472.85 million, up 42.6% from the prior year.
- Cash & Equivalents has a five-year compound annual growth rate of -0.4% (years ended Dec 2020 to Dec 2025).
- By year, Cash & Equivalents came in at $331.61 million in the year ended Dec 31, 2024 (-40.0%), $552.66 million in the year ended Dec 31, 2023 (+26.3%), $437.56 million in the year ended Dec 31, 2022 (-47.1%) and $827.58 million in the year ended Dec 31, 2021 (+71.5%).
- Five-year quarterly Cash & Equivalents spans a low of $203.46 million in the quarter ended Sep 30, 2025 and a high of $800.01 million in the quarter ended Dec 31, 2021.
- Year over year, Cash & Equivalents has now increased in each of the last three quarters, with an average decline of 8.5% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was the quarter ended Sep 30, 2022 (growth of 79.3%); the low point was the quarter ended Dec 31, 2022 (a decline of 47.1%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $454.15 million (quarter ended Mar 31, 2026), $487.17 million (quarter ended Dec 31, 2025) and $203.46 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.26 Bn | 36.10 Bn | 1.44 Bn | 1.91 Bn |
| 2 | Medpace Holdings | 17.42 Bn | 15.48 Bn | 201.64 Mn | 502.69 Mn |
| 3 | Charles River Laboratories International | 14.08 Bn | 13.32 Bn | 363.37 Mn | 192.03 Mn |
| 4 | Icon | 13.02 Bn | 10.12 Bn | 479.29 Mn | 928.39 Mn |
| 5 | Fortrea Holdings | 1.90 Bn | 1.28 Bn | 139.20 Mn | 168.60 Mn |
| 6 | Ginkgo Bioworks Holdings | 817.41 Mn | 55.33 Mn | 18.44 Mn | 84.54 Mn |
| 7 | Evotec SE | 608.00 Mn | -965.22 Mn | - | 404.92 Mn |
| 8 | Champions Oncology | 69.59 Mn | 45.24 Mn | 7.70 Mn | 4.40 Mn |
| 9 | MindWalk Holdings | 62.13 Mn | 26.34 Mn | 1.61 Mn | 5.47 Mn |
| 10 | Natural Alternatives International | 8.98 Mn | -19.10 Mn | 1.73 Mn | 7.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 404.92 Mn |
| Mar 31, 2026 | 454.15 Mn |
| Dec 31, 2025 | 487.17 Mn |
| Sep 30, 2025 | 203.46 Mn |
| Jun 30, 2025 | 303.17 Mn |
| Mar 31, 2025 | 322.28 Mn |
| Dec 31, 2024 | 327.40 Mn |
| Sep 30, 2024 | 254.02 Mn |
| Jun 30, 2024 | 550.19 Mn |
| Mar 31, 2024 | 555.03 Mn |
| Dec 31, 2023 | 549.71 Mn |
| Sep 30, 2023 | 451.93 Mn |
| Jun 30, 2023 | 500.64 Mn |
| Mar 31, 2023 | 445.60 Mn |
| Dec 31, 2022 | 423.56 Mn |
| Sep 30, 2022 | 705.11 Mn |
| Jun 30, 2022 | 746.22 Mn |
| Mar 31, 2022 | 741.29 Mn |
| Dec 31, 2021 | 800.01 Mn |
| Sep 30, 2021 | 393.18 Mn |
API Access
Evotec SE Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "EVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();